Want to see SE:EXPRS2 full AI Analyst Report?
Compare ExpreS2ion Biotech Holding AB (EXPRS2) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| SE:EXPRS2ExpreS2ion Biotech Holding AB | SEK 0.93 | SEK 36.86M | -0.14 | -84.87% | ― | SE:EXPRS2 | ||||
| SE:BINVBioInvent International AB | SEK 5.43 | SEK 357.32M | -0.73 | -83.69% | ― | SE:EXPRS2 vs SE:BINV | ||||
| SE:XBRANEXbrane Biopharma AB | SEK 14.15 | SEK 291.57M | -5.90 | 35.54% | ― | SE:EXPRS2 vs SE:XBRANE | ||||
| SE:IVACCIntervacc AB | SEK 0.77 | SEK 263.11M | -2.92 | -22.80% | ― | SE:EXPRS2 vs SE:IVACC | ||||
| SE:IMMUImmunicum AB | SEK 5.50 | SEK 348.89M | -3.07 | -25.68% | ― | SE:EXPRS2 vs SE:IMMU | ||||
| SE:CANTACantargia AB | SEK 1.60 | SEK 451.68M | 2.35 | -53.02% | Moderate Buy | SE:EXPRS2 vs SE:CANTA |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| SE:EXPRS2 | ExpreS2ion Biotech Holding AB | 0.93 | -5.16 | -84.67% | |
| SE:BINV | BioInvent International AB | 5.43 | -28.47 | -83.98% | |
| SE:XBRANE | Xbrane Biopharma AB | 14.15 | 3.35 | 31.02% | |
| SE:IVACC | Intervacc AB | 0.77 | -0.20 | -20.33% | |
| SE:IMMU | Immunicum AB | 5.50 | -1.89 | -25.58% | |
| SE:CANTA | Cantargia AB | 1.60 | -1.97 | -55.13% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts